ID   A121(P)
AC   CVCL_G294
SY   A121; A121(Primary)
DR   ChEMBL-Cells; CHEMBL3308020
DR   ChEMBL-Targets; CHEMBL613106
DR   PubChem_Cell_line; CVCL_G294
DR   Wikidata; Q54606378
RX   PubMed=2910777;
RX   PubMed=7959296;
CC   Doubling time: 22 hours (PubMed=2910777).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9192; Ovarian carcinosarcoma
DI   ORDO; Orphanet_213512; Malignant mixed Mullerian tumor of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8KL ! A121(A)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
RX   PubMed=2910777; DOI=10.1016/S0090-8258(89)80028-9;
RA   Crickard K., Niedbala M.J., Crickard U., Yoonessi M., Sandberg A.A.,
RA   Okuyama K., Bernacki R.J., Satchidanand S.K.;
RT   "Characterization of human ovarian and endometrial carcinoma cell
RT   lines established on extracellular matrix.";
RL   Gynecol. Oncol. 32:163-173(1989).
//
RX   PubMed=7959296; DOI=10.1006/gyno.1994.1290;
RA   Crickard K., Gross J.L., Crickard U., Yoonessi M., Lele S.,
RA   Herblin W.F. Jr., Eidsvoog K.;
RT   "Basic fibroblast growth factor and receptor expression in human
RT   ovarian cancer.";
RL   Gynecol. Oncol. 55:277-284(1994).
//